SCHEMBL6925799

SCHEMBL6925799

O=C(O)C1=CC=CC=NS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6242018 0.67
SCHEMBL20271920 0.61
SCHEMBL6925803 0.60
SCHEMBL30538597 0.59
SCHEMBL23829645 0.58
SCHEMBL3773138 0.58
SCHEMBL8692995 0.56
Benzene SCHEMBL27580567 0.56
SCHEMBL23833210 0.55
SCHEMBL19750859 0.54 TSHR (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235792-A4 PREPARATION OF [4S-(4ALPHA,7ALPHA,10ABETA)]-4-AMINO-OCTAHYDRO-5-OXO-7H-PYRIDO 2,1-B] 1,3]THIAZEPINE-7-CARBOXYLIC ACID, METHYL ESTER AND SALTS THEREOF VIA NOVEL DISULFIDES BRISTOL MYERS SQUIBB CO (US) 2003-06-25 EP claimed
EP-1235792-A1 PREPARATION OF [4S-(4ALPHA,7ALPHA,10ABETA)]-4-AMINO-OCTAHYDRO-5-OXO-7H-PYRIDO 2,1-B] 1,3]THIAZEPINE-7-CARBOXYLIC ACID, METHYL ESTER AND SALTS THEREOF VIA NOVEL DISULFIDES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-04 EP claimed
EP-1051419-A4 DEPROTECTION AND RECRYSTALLIZATION PROCESSES BRISTOL MYERS SQUIBB CO (US) 2002-08-28 EP claimed
WO-2002042258-A1 PREPARATION OF [4S-(4α,7α,10Aβ)]-4-AMINO-OCTAHYDRO-5-OXO-7H-PYRIDO[2,1-B][1,3]THIAZEPINE-7-CARBOXYLIC ACID, METHYL ESTER AND SALTS THEREOF VIA NOVEL DISULFIDES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-05-30 WO claimed
EP-1051419-A1 DEPROTECTION AND RECRYSTALLIZATION PROCESSES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-11-15 EP claimed
WO-1999035145-A1 DEPROTECTION AND RECRYSTALLIZATION PROCESSES BRISTOL-MYERS SQUIBB COMPANY (US) 1999-07-15 WO claimed
US-20230019129-A1 HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2023-01-19 US disclosed
CN-113613724-A Compounds useful in HIV therapy 葛兰素史克知识产权开发有限公司 2021-11-05 CN disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
US-10947224-B2 Hepatitis B core protein allosteric modulators INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2021-03-16 US disclosed
EP-3607950-A2 HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS Indiana University Research & Technology Corporation (US) 2020-02-12 EP disclosed
US-10183936-B2 Hepatitis B core protein allosteric modulators INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2019-01-22 US disclosed
US-20180273521-A1 HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS Indiana University Research and Technology Corporationt (US) 2018-09-27 US disclosed
EP-1051419-A1 DEPROTECTION AND RECRYSTALLIZATION PROCESSES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-11-15 EP disclosed
WO-2000057883-A1 USE OF VASOPEPTIDASE INHIBITORS TO TREAT ANGINA PECTORIS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-10-05 WO disclosed
WO-2000003981-A2 PREPARATION OF (S)-2-AMINO-6,6-DIMETHOXYHEXANOIC ACID METHYL ESTER VIA NOVEL DIOXOLANES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-01-27 WO disclosed
WO-1999035145-A1 DEPROTECTION AND RECRYSTALLIZATION PROCESSES BRISTOL-MYERS SQUIBB COMPANY (US) 1999-07-15 WO disclosed
US-5756832-A REACTING AN ALDHYDE WITH AN ORTHOFORMATE IN THE PRESENCE OF AN ACID CATALYST AND AN ALCOHOL BRISTOL-MYERS SQUIBB CO. (US) 1998-05-26 US disclosed
US-5672599-A DUAL ACTION ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND NEUTRAL ENDOPEPTIDASE INHIBITORS; TREATMENT OF CARDIOVASCULAR DISORDERS BRISTOL-MYERS SQUIBB CO. (US) 1997-09-30 US disclosed
US-5670699-A Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring BRISTOL-MYERS SQUIBB CO. (US) 1997-09-23 US disclosed